Clinical Trials Browser

Phase 2 × Kidney Neoplasms × Bevacizumab × Clear all

NCT01130519 2025-02-21

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

Phase 2 Completed

83 enrolled 17 charts

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, Kidney Neoplasms

NCT00113217 2020-09-23

Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma

Phase 2 Completed

52 enrolled 5 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00853021 2019-06-05

Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney

Phase 2 Completed

26 enrolled 11 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00782275 2018-01-24

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

Phase 2 Completed

41 enrolled 9 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00496587 2017-07-19

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma

Phase 2 Completed

34 enrolled 9 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00651482 2017-04-11

Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)

Phase 2 Terminated

10 enrolled 14 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01264341 2017-02-14

Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma

Phase 2 Terminated

Kidney Neoplasms

NCT00440973 2016-03-17

Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00601926 2015-06-15

Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Terminated

5 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00455975 2014-12-22

High-dose Bevacizumab in Advanced Renal Carcinoma Patients

Phase 2 Completed

119 enrolled 8 charts

Kidney Neoplasms, Adenocarcinoma, Clear Cell

NCT00193154 2014-04-01

OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma

Phase 2 Completed

Kidney Neoplasms

NCT00873236 2013-08-12

MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00323739 2013-07-26

Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma

Phase 2 Completed

80 enrolled 8 charts

Kidney Neoplasms